Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TDF/FTC to Reduce NNRTI Resistance in PMTCT
NCT00204308Phase 2Completed
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Mar 2005
- Primary completion
- May 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of emtricitabine + tenofovir disoproxil in human immunodeficiency virus infection (HIV), sponsored by University of North Carolina at Chapel Hill. Started Mar 2005; status: completed.
02
Drugs
emtricitabine + tenofovir disoproxil
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00204308.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00204308.